Double Kissing-crush vs Controlled Balloon-crush Techniques For Complex Coronary Bfurcation Lesions
Comparison of Cardiovascular Outcomes of Double Kissing-crush vs Controlled Balloon-crush Techniques For Complex Coronary Bifurcation Lesions
1 other identifier
observational
300
1 country
2
Brief Summary
The Crush technique for coronary bifurcation lesions has evolved significantly since its introduction to the literature by Colombo et al. in 2003, with several iterations, including double kissing balloon inflation. The main disadvantage of the historical Crush technique is the low success rate of the final kissing balloon inflation. An improvement came with the introduction of double kissing crush stenting aiming for the shorter protrusion and kissing balloon dilation performed before and after main branch stent implantation. The double kissing crush provides a significant reduction in major adverse cardiovascular events compared to Provisional stenting, Crush, and Culotte techniques. Recently, a novel modified mini-crush technique (controlled balloon-crush) has been introduced to the literature and is one of the most up-to-date crush techniques. The main advantage of this technique over the contemporary mini-crush technique is that the side branch can be easily rewired, and the 1:1 size non-compliant balloon can easily pass through the crushed stent structure in the ostial part of the side branch. The basic rationale of this is that the crushing of the side branch stent is done in a more controlled manner (by slowly deflation of the side branch stent balloon), and this causes less disruption of the stent cells. To date, no data compares the mid-term outcomes of double kissing crush and controlled balloon-crush stenting techniques in patients with complex coronary bifurcation lesions. Hence, this study aimed to determine the clinical results of double kissing crush and controlled balloon-crush techniques under mid-term follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 8, 2025
CompletedFirst Posted
Study publicly available on registry
April 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
April 17, 2025
April 1, 2025
1.6 years
April 8, 2025
April 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Primary endpoint (Target lesion failure)
Target lesion failure (%) is defined as the combination of cardiac death (%), target vessel myocardial infarction (%), or target lesion revascularization (%) rates.
36 months
Study Arms (2)
Controlled balloon-crush Group
Double kissing-crush stenting Group
Eligibility Criteria
Complex coronary bifurcation disease
You may qualify if:
- Aged \>18
- PCI with either DK-crush or Controlled balloon-crush
- Complex coronary bifurcation lesion (Medina 0.1.1, Medina 1.1.1)
You may not qualify if:
- Non-complex bifurcation anatomy
- Bail-out 2-stent (reverse modified mini-crush)
- ST-elevation myocardial infarction
- Cardiogenic shock status
- In-stent restenosis
- A previous of coronary artery bypass grafting
- Implantation of bare-metal stent
- End-stage hepatic or renal disease
- \<1-year life expectancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istanbul Mehmet Akif Ersoy Educational and Training Hospitallead
- Sisli Hamidiye Etfal Training and Research Hospitalcollaborator
- Başakşehir Çam & Sakura City Hospitalcollaborator
- Bagcilar Training and Research Hospitalcollaborator
- Ankara Etlik City Hospitalcollaborator
- Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospitalcollaborator
- Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospitalcollaborator
- Istanbul Medipol University Hospitalcollaborator
Study Sites (2)
Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital
Istanbul, 33484, Turkey (Türkiye)
Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital
Istanbul, 33484, Turkey (Türkiye)
Central Study Contacts
Abdullah Doğan, MD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 8, 2025
First Posted
April 17, 2025
Study Start
April 1, 2025
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
April 17, 2025
Record last verified: 2025-04